Deepull
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
Deepull has raised €93M across 6 funding rounds from 19 investors, most recently a Series C round in Apr 2025. Based in Barcelona, Spain; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, SpainFounded 2019
Total raised
€93M
€92,750,000
Funding rounds
6
Investors
19
distinct backers
Active since
2020-07
latest 2025-04
Funding by year
EUR raised per yearDeepull — funding by year — interactive chart.
Data table
| Deepull — funding by year | |
|---|---|
| 2020 | €3.5M |
| 2022 | €35M |
| 2023 | €4.0M |
| 2025 | €50M |
Signals
High confidenceRaise-next likelihood76
base rate 50% for Series C
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood31
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 6 rounds raised
- ▲ 7y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-29 | Series C | €50M | Aliath Bioventures,Asabys Partners,Axis-Ico,CGHealth Ventures,Columbus Venture Partners,Gesamo+4 more | View deal → |
| 2023-03-02 | Other | €4.0M | Sabadell Asabys | View deal → |
| 2022-12-14 | Debt | €20M | European Investment Bank (EIB) | View deal → |
| 2022-11-15 | Other | €2.3M | Alta Life Sciences,CDTI,FCR | View deal → |
| 2022-10-20 | Series B | €13M | Alta Life Sciences,Axis Participaciones Empresariales,Innvest,Kurma Partners,UI Investissement | View deal → |
| 2020-07-08 | Series A | €3.5M | Alta Life Sciences,Kurma Partners | View deal → |
Investors
19Aliath BioventuresAlta Life SciencesAsabys PartnersAxis Participaciones EmpresarialesAxis-IcoCDTICGHealth VenturesColumbus Venture PartnersEuropean Investment Bank (EIB)FCRGesamoInnvestInnvierte-CDTIKurma PartnersMérieux Equity PartnersPanakès PartnersSabadell AsabysUI InvestissementWe Venture Capital
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData